Mads Gyrd‐Hansen

6.4k total citations · 1 hit paper
40 papers, 4.1k citations indexed

About

Mads Gyrd‐Hansen is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Mads Gyrd‐Hansen has authored 40 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Mads Gyrd‐Hansen's work include interferon and immune responses (13 papers), Cell death mechanisms and regulation (13 papers) and NF-κB Signaling Pathways (13 papers). Mads Gyrd‐Hansen is often cited by papers focused on interferon and immune responses (13 papers), Cell death mechanisms and regulation (13 papers) and NF-κB Signaling Pathways (13 papers). Mads Gyrd‐Hansen collaborates with scholars based in Denmark, United Kingdom and Germany. Mads Gyrd‐Hansen's co-authors include Pascal Meier, Berthe Katrine Fiil, Rune Busk Damgaard, Marja Jäättelä, David Komander, Jesper Nylandsted, Matouš Hrdinka, Nicole Fehrenbacher, P.R. Elliott and Kirstin Keusekotten and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Mads Gyrd‐Hansen

39 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

2010 656 citations Mads Gyrd‐Hansen, Pascal Meier Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Mads Gyrd‐Hansen

Since Specialization

Citations

This map shows the geographic impact of Mads Gyrd‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads Gyrd‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads Gyrd‐Hansen more than expected).

Fields of papers citing papers by Mads Gyrd‐Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads Gyrd‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads Gyrd‐Hansen. The network helps show where Mads Gyrd‐Hansen may publish in the future.

Co-authorship network of co-authors of Mads Gyrd‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Mads Gyrd‐Hansen. A scholar is included among the top collaborators of Mads Gyrd‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads Gyrd‐Hansen. Mads Gyrd‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivo 2024 ·Molecular Cell ·Anna Vind, Zhenhua Wu, (unknown), Goda Snieckute, Gee Ann Toh, (unknown), (unknown), Peter Haahr, Thomas Levin Andersen, Melanie Blasius, Li Fang Koh, (unknown), John Common, Mads Gyrd‐Hansen, Franklin L. Zhong, Simon Bekker‐Jensen	10
2	Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1 2022 ·EMBO Reports ·(unknown), Chris Kedong Wang, Xuan Wang‐Kan, Manja Idorn, (unknown), Felix Zhou, Berthe Katrine Fiil, (unknown), Susana Orozco, (unknown), Carol S. Leung, Xin Lü, Katrin Bagola, Jan Rehwinkel, Andrew Oberst, Jonathan Maelfait, Søren R. Paludan, Mads Gyrd‐Hansen	47
3	Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Lisa Schlicher, (unknown), Mads Gyrd‐Hansen, Alexei Degterev, Gregory D. Cuny	14
4	RIPK2 NODs to XIAP and IBD 2020 ·Seminars in Cell and Developmental Biology ·(unknown), Mads Gyrd‐Hansen	36
5	Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold 2020 ·European Journal of Medicinal Chemistry ·Chalada Suebsuwong, Bing Dai, Daniel M. Pinkas, (unknown), Li Li, Joshua C. Bufton, Lisa Schlicher, Mads Gyrd‐Hansen, Ming Hu, Alex N. Bullock, Alexei Degterev, Gregory D. Cuny	17
6	The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation 2017 ·Molecular Cell ·Matouš Hrdinka, Mads Gyrd‐Hansen	96
7	CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling 2016 ·Cell Reports ·Matouš Hrdinka, Berthe Katrine Fiil, (unknown), (unknown), Katrin Bagola, Monica Yabal, P.R. Elliott, Rune Busk Damgaard, David Komander, Philipp J. Jost, Mads Gyrd‐Hansen	119
8	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling 2016 ·Molecular Cell ·P.R. Elliott, (unknown), Matouš Hrdinka, Katrin Bagola, Berthe Katrine Fiil, Stephen H. McLaughlin, Jane L. Wagstaff, Norbert Volkmar, John C. Christianson, Benedikt M. Kessler, Stefan M.V. Freund, David Komander, Mads Gyrd‐Hansen	121
9	Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors 2015 ·Chemistry & Biology ·Peter Canning, (unknown), Tobias Schwerd, Matouš Hrdinka, Jenny L. Maki, Danish Saleh, Chalada Suebsuwong, Soumya S. Ray, Paul E. Brennan, Gregory D. Cuny, Holm H. Uhlig, Mads Gyrd‐Hansen, Alexei Degterev, Alex N. Bullock	77
10	OTULIN Restricts Met1-Linked Ubiquitination to Control Innate Immune Signaling 2013 ·Molecular Cell ·Berthe Katrine Fiil, Rune Busk Damgaard, Sebastian Wagner, Kirstin Keusekotten, Melanie Fritsch, Simon Bekker‐Jensen, Niels Mailand, Chunaram Choudhary, David Komander, Mads Gyrd‐Hansen	198
11	OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin 2013 ·Cell ·Kirstin Keusekotten, P.R. Elliott, (unknown), Berthe Katrine Fiil, Rune Busk Damgaard, Yogesh Kulathu, Tobias Wauer, Manuela K. Hospenthal, Mads Gyrd‐Hansen, Daniel Krappmann, Kay Hofmann, David Komander	362
12	Disease‐causing mutations in the XIAP BIR 2 domain impair NOD 2‐dependent immune signalling 2013 ·EMBO Molecular Medicine ·Rune Busk Damgaard, Berthe Katrine Fiil, Carsten Speckmann, Monica Yabal, Udo zur Stadt, Simon Bekker‐Jensen, Philipp J. Jost, Stephan Ehl, Niels Mailand, Mads Gyrd‐Hansen	108
13	The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity 2012 ·Molecular Cell ·Rune Busk Damgaard, Ueli Nachbur, Monica Yabal, W. Wei‐Lynn Wong, Berthe Katrine Fiil, (unknown), Eva Rieser, (unknown), Aleksandra Bankovacki, Christian Peschel, Jürgen Ruland, Simon Bekker‐Jensen, Niels Mailand, Thomas Kaufmann, Andreas Strasser, Henning Walczak, John Silke, Philipp J. Jost, Mads Gyrd‐Hansen	293
14	IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer breakdown → 2010 ·Nature reviews. Cancer ·Mads Gyrd‐Hansen, Pascal Meier	656
15	Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death 2007 ·Molecular Cancer Therapeutics ·Christina W. Yde, Mads Gyrd‐Hansen, Anne E. Lykkesfeldt, Olaf‐Georg Issinger, Jan Stenvang	23
16	Heregulin‐induced epigenetic regulation of the utrophin‐A promoter 2007 ·FEBS Letters ·(unknown), Mads Gyrd‐Hansen, Santhosh M. Baby, Olga Lozynska, Thomas Krag, Claus J. Jensen, Morten Frödin, Tejvir S. Khurana	16
17	Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9 2006 ·Molecular and Cellular Biology ·Mads Gyrd‐Hansen, Thomas Farkas, Nicole Fehrenbacher, Lone Bastholm, Maria Høyer-Hansen, Folmer Elling, David Wallach, Richard A. Flavell, Guido Kroemer, Jesper Nylandsted, Marja Jäättelä	93
18	JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways 2003 ·Cell Death and Differentiation ·Nicole Dietrich, Jacob Thastrup, Christian Holmberg, Mads Gyrd‐Hansen, Nicole Fehrenbacher, Ulrik Lademann, Mads Lerdrup, Thomas Herdegen, Marja Jäättelä, Tuula Kallunki	54
19	Sp1 and the ets-related transcription factor complex GABPα/β functionally cooperate to activate the utrophin promoter 2002 ·Journal of the Neurological Sciences ·Mads Gyrd‐Hansen, Thomas Krag, Alan G. Rosmarin, Tejvir S. Khurana	20
20	Harnessing the potential of dystrophin‐related proteins for ameliorating Duchenne’s muscular dystrophy 2001 ·Acta Physiologica Scandinavica ·Thomas Krag, Mads Gyrd‐Hansen, Tejvir S. Khurana	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact